Brief: Centessa Q2 Loss Per Share $0.65
Aug 16 (Reuters) - Centessa Pharmaceuticals PLC 260y.F :
* Q2 LOSS PER SHARE $0.65
* CENTESSA- EXPECTS CASH, EQUIVALENTS AS OF JUNE 30, TO FUND
ITS
OPERATIONS UNTIL END OF 2023
Source text for Eikon: ID:nGNXdNg8t
Further company coverage: 260y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Centessa Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Acquisition Of Centessa By Lilly Approved By The High Court Of Justice Of England And Wales
Street View: Lilly's $7.8 billion Centessa buyout validates sleep‑drug market
Press Digest: New York Times business news - April 1